230 related articles for article (PubMed ID: 16300702)
1. Prediction of benignity or malignancy of a lesion using BI-RADS.
Masroor I
J Coll Physicians Surg Pak; 2005 Nov; 15(11):686-8. PubMed ID: 16300702
[TBL] [Abstract][Full Text] [Related]
2. BI-RADS categorization as a predictor of malignancy.
Orel SG; Kay N; Reynolds C; Sullivan DC
Radiology; 1999 Jun; 211(3):845-50. PubMed ID: 10352614
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of assigning BI-RADS category-3 to breast lesion with respect to follow-up.
Masroor I
J Coll Physicians Surg Pak; 2008 Apr; 18(4):209-12. PubMed ID: 18474152
[TBL] [Abstract][Full Text] [Related]
4. Positive predictive value of breast cancer in the lesions categorized as BI-RADS category 5.
Wiratkapun C; Lertsithichai P; Wibulpholprasert B
J Med Assoc Thai; 2006 Aug; 89(8):1253-9. PubMed ID: 17048437
[TBL] [Abstract][Full Text] [Related]
5. Influence of age on PPV of sonographic BI-RADS categories 3, 4, and 5.
Fu CY; Hsu HH; Yu JC; Hsu GC; Hsu KF; Chan DC; Ku CH; Lu TC; Chu CH
Ultraschall Med; 2011 Jan; 32 Suppl 1():S8-13. PubMed ID: 20603785
[TBL] [Abstract][Full Text] [Related]
6. Biopsy rate and positive predictive value for breast cancer in BI-RADS category 4 breast lesions.
Wiratkapun C; Bunyapaiboonsri W; Wibulpolprasert B; Lertsithichai P
J Med Assoc Thai; 2010 Jul; 93(7):830-7. PubMed ID: 20649064
[TBL] [Abstract][Full Text] [Related]
7. The breast imaging reporting and data system: positive predictive value of mammographic features and final assessment categories.
Liberman L; Abramson AF; Squires FB; Glassman JR; Morris EA; Dershaw DD
AJR Am J Roentgenol; 1998 Jul; 171(1):35-40. PubMed ID: 9648759
[TBL] [Abstract][Full Text] [Related]
8. The value of breast MRI for BI-RADS category 4B mammographic microcalcification: based on the 5
Eun NL; Son EJ; Gweon HM; Youk JH; Kim JA
Clin Radiol; 2018 Aug; 73(8):750-755. PubMed ID: 29853301
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
[TBL] [Abstract][Full Text] [Related]
10. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value.
Lazarus E; Mainiero MB; Schepps B; Koelliker SL; Livingston LS
Radiology; 2006 May; 239(2):385-91. PubMed ID: 16569780
[TBL] [Abstract][Full Text] [Related]
11. Mammographic characteristics and vacuum-assisted breast biopsy (VABB) of non-palpable breast lesions.
Ventrella V; Tufaro A; Zito FA; Addante M; Stea B; Dentamaro R; D'Amico C; Paradiso A
Acta Radiol; 2011 Jul; 52(6):602-7. PubMed ID: 21565889
[TBL] [Abstract][Full Text] [Related]
12. Prediction for Breast Cancer in BI-RADS Category 4 Lesion Categorized by Age and Breast Composition of Women in Songklanagarind Hospital.
Noonpradej S; Wangkulangkul P; Woodtichartpreecha P; Laohawiriyakamol S
Asian Pac J Cancer Prev; 2021 Feb; 22(2):531-536. PubMed ID: 33639670
[TBL] [Abstract][Full Text] [Related]
13. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41.
Hooley RJ; Greenberg KL; Stackhouse RM; Geisel JL; Butler RS; Philpotts LE
Radiology; 2012 Oct; 265(1):59-69. PubMed ID: 22723501
[TBL] [Abstract][Full Text] [Related]
14. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
[TBL] [Abstract][Full Text] [Related]
15. Computer-aided classification of BI-RADS category 3 breast lesions.
Buchbinder SS; Leichter IS; Lederman RB; Novak B; Bamberger PN; Sklair-Levy M; Yarmish G; Fields SI
Radiology; 2004 Mar; 230(3):820-3. PubMed ID: 14739315
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
Uematsu T; Yuen S; Kasami M; Uchida Y
Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
[TBL] [Abstract][Full Text] [Related]
17. BI-RADS Category 5 Assessments at Diagnostic Breast Imaging:Outcomes Analysis Based on Lesion Descriptors.
Yao MM; Joe BN; Sickles EA; Lee CS
Acad Radiol; 2019 Aug; 26(8):1048-1052. PubMed ID: 30195413
[TBL] [Abstract][Full Text] [Related]
18. Effect on biopsy technique of the breast imaging reporting and data system (BI-RADS) for nonpalpable mammographic abnormalities.
Ball CG; Butchart M; MacFarlane JK
Can J Surg; 2002 Aug; 45(4):259-63. PubMed ID: 12174979
[TBL] [Abstract][Full Text] [Related]
19. Revisiting the mammographic follow-up of BI-RADS category 3 lesions.
Varas X; Leborgne JH; Leborgne F; Mezzera J; Jaumandreu S; Leborgne F
AJR Am J Roentgenol; 2002 Sep; 179(3):691-5. PubMed ID: 12185047
[TBL] [Abstract][Full Text] [Related]
20. [Stereotactic Mammotome breast biopsy: routine clinical experience and correlation with BI-RADS--classification and histopathology].
Michel SC; Löw R; Singer G; Otto R; Hohl M; Kubik RA
Praxis (Bern 1994); 2007 Sep; 96(39):1459-74. PubMed ID: 17966279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
